HQH - Abrdn Healthcare Investors
Price:
--
--
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 99.8 | 10.8 | 10.3 | 8.3 | 6.5 | 8.9 | 7.6 | 6.8 | 5.6 | 4.8 | 4.3 | 2.1 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 99.8 | 10.8 | 10.3 | 8.3 | 6.5 | 8.9 | 7.6 | 6.8 | 5.6 | 4.8 | 4.3 | 2.1 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 1.1 | 11.0 | 11.5 | 11.9 | 12.7 | 10.9 | 10.5 | 10.9 | 10.8 | 11.1 | 12.2 | 9.3 |
| Other Expenses | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 1.2 | 11.0 | 11.5 | 11.9 | 12.7 | 10.9 | 10.5 | 10.9 | 10.8 | 11.1 | 12.2 | 9.3 |
| Operating Income | ||||||||||||
| Operating Income | 98.6 | (0.2) | (1.2) | (3.7) | (6.2) | (2.0) | (2.9) | (4.1) | (5.2) | (6.3) | (7.9) | (7.2) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 1.0 | 2.0 | 0.6 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||
| EBITDA | 98.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 98.6 | (0.2) | (1.2) | (3.7) | (6.2) | (2.0) | (2.9) | (4.1) | (5.2) | (6.3) | (7.9) | (7.2) |
| Income Before Tax | 98.6 | 184.9 | 56.3 | (194.2) | 155.2 | 241.2 | (145.3) | 69.2 | 121.3 | (56.0) | 96.2 | 222.0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 98.6 | 184.9 | 56.3 | (194.2) | 155.2 | 241.2 | (145.3) | 69.2 | 121.3 | (56.0) | 96.2 | 222.0 |
| Per Share Data | ||||||||||||
| EPS (Basic) | 1.84 | 3.55 | 1.14 | -4.10 | 3.49 | 5.50 | -3.39 | 1.64 | 2.98 | -1.44 | 2.58 | 6.20 |
| EPS (Diluted) | 1.84 | 3.55 | 1.14 | -4.10 | 3.49 | 5.50 | -3.39 | 1.64 | 2.98 | -1.44 | 2.58 | 6.20 |
| Shares Outstanding | 53.6 | 52.1 | 49.4 | 47.3 | 45.4 | 43.9 | 42.8 | 42.2 | 40.6 | 39.0 | 37.3 | 35.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 1.7 | 0.0 | 6.5 | 0.0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 2.5 | 0.5 | 6.9 | 2.9 | 4.0 | 4.3 | 9.0 | 0.5 | 0.2 | 9.6 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0.0 | 32.7 | 39.8 | 8.3 | 2.5 | 16.7 | 18.1 | 26.5 | 48.6 |
| Total Current Assets | 2.6 | 0.6 | 39.6 | 42.7 | 12.4 | 6.8 | 27.4 | 18.6 | 33.1 | 58.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1,079.0 | 1,038.8 | 824.7 | 804.8 | 1,071.7 | 996.8 | 816.9 | 1,017.8 | 1,000.1 | 907.0 |
| Other Non-Current Assets | 15.6 | 21.6 | 68.2 | 78.8 | 88.4 | 52.2 | 33.5 | 49.0 | 34.1 | 44.3 |
| Total Non-Current Assets | 1,094.6 | 1,060.4 | 892.8 | 883.6 | 1,160.1 | 1,049.0 | 850.4 | 1,066.9 | 1,034.3 | 951.3 |
| Total Assets | 1,097.3 | 1,061.0 | 932.5 | 926.3 | 1,172.5 | 1,055.8 | 877.8 | 1,085.5 | 1,067.4 | 1,009.6 |
| Current Liabilities | ||||||||||
| Account Payables | 1.2 | 0 | 0 | 0 | 0 | 0 | 6.0 | 2.6 | 8.6 | 33.7 |
| Short-Term Debt | 0 | 0 | 0 | 8.5 | 11.3 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0.3 | 0 | 0 | 3.0 | 0.0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 1.2 | 1.4 | 1.1 | 9.7 | 15.6 | 1.1 | 6.9 | 3.8 | 9.8 | 34.8 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.2 | 0 | 1.1 | 0 | 15.6 | 0.0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 2.2 | 0 | 1.1 | 0 | 15.6 | 0.0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.4 | 1.4 | 1.1 | 9.7 | 15.6 | 1.1 | 6.9 | 3.8 | 9.8 | 34.8 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 796.1 | 784.5 | 749.6 | 712.5 |
| Retained Earnings | 101.6 | 117.9 | 6.0 | 24.8 | 303.1 | 239.5 | 74.7 | 297.3 | 308.1 | 262.3 |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 1,093.8 | 1,059.6 | 931.3 | 916.6 | 1,156.9 | 1,054.7 | 870.8 | 1,081.7 | 1,057.6 | 974.8 |
| Total Liabilities & Equity | 1,097.3 | 1,061.0 | 932.5 | 926.3 | 1,172.5 | 1,055.8 | 877.8 | 1,085.5 | 1,067.4 | 1,009.6 |
| Debt Metrics | ||||||||||
| Total Debt | 0 | 0 | 0 | 8.5 | 11.3 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (0.0) | (0.0) | (0.0) | 8.5 | 11.3 | 0 | (1.7) | (0.0) | (6.5) | (0.0) |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 184.9 | 56.3 | (194.2) | 155.2 | 241.2 | (145.3) | 69.2 | 121.3 | (56.0) | 96.2 |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | (184.9) | (56.3) | 194.2 | (155.2) | (241.2) | 145.3 | (69.2) | (121.3) | 56.0 | (96.2) |
| Operating Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | ||||||||||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Position | ||||||||||
| Net Change in Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Cash at Beginning | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Cash at End | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 99.8 | 10.8 | 10.3 | 8.3 | 6.5 | 8.9 | 7.6 | 6.8 | 5.6 | 4.8 | 4.3 | 2.1 |
| Gross Profit | 99.8 | 10.8 | 10.3 | 8.3 | 6.5 | 8.9 | 7.6 | 6.8 | 5.6 | 4.8 | 4.3 | 2.1 |
| Operating Income | 98.6 | (0.2) | (1.2) | (3.7) | (6.2) | (2.0) | (2.9) | (4.1) | (5.2) | (6.3) | (7.9) | (7.2) |
| Net Income | 98.6 | 184.9 | 56.3 | (194.2) | 155.2 | 241.2 | (145.3) | 69.2 | 121.3 | (56.0) | 96.2 | 222.0 |
| EPS (Diluted) | 1.84 | 3.55 | 1.14 | -4.10 | 3.49 | 5.50 | -3.39 | 1.64 | 2.98 | -1.44 | 2.58 | 6.20 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 1.7 | 0.0 | 6.5 | 0.0 | ||
| Total Assets | 1,097.3 | 1,061.0 | 932.5 | 926.3 | 1,172.5 | 1,055.8 | 877.8 | 1,085.5 | 1,067.4 | 1,009.6 | ||
| Total Debt | 0 | 0 | 0 | 8.5 | 11.3 | 0 | 0 | 0 | 0 | 0 | ||
| Stockholders' Equity | 1,093.8 | 1,059.6 | 931.3 | 916.6 | 1,156.9 | 1,054.7 | 870.8 | 1,081.7 | 1,057.6 | 974.8 | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||